Lv1
30 积分 2022-03-16 加入
Effectiveness and safety of upadacitinib retreatment after withdrawal in moderate-to-severe atopic dermatitis: a retrospective study
2个月前
已完结
Roadmap for Optimizing and Broadening Antibody-Based PROTACs for Degradation of Cell Surface Proteins
2个月前
已完结
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
2个月前
已完结
Biophysical and Computational Approaches to Study Ternary Complexes: A ‘Cooperative Relationship’ to Rationalize Targeted Protein Degradation
3个月前
已完结
Targeting cancer with small-molecule pan-KRAS degraders
3个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
3个月前
已完结
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
3个月前
已完结
Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines
3个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
3个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
4个月前
已完结
皖公网安备34019202002308
